Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Ergot derivatives")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1904

  • Page / 77
Export

Selection :

  • and

Quantitative studies of the effects of aging, meclofenoxate, and dihydroergotoxine on intraneuronal lipopigment accumulation in the ratDOWSON, J. H.Experimental gerontology. 1985, Vol 20, Num 6, pp 333-340, issn 0531-5565Article

Pharmacodynamic and pharmacokinetic features of cabergoline: Rationale for use in Parkinson's diseaseFARIELLO, R. G.Drugs (Basel). 1998, Vol 55, pp 10-16, issn 0012-6667, SUP1Conference Paper

ACCIDENTS ISCHEMIQUES DUS AUX DERIVES DE L'ERGOT DE SEIGLE: A PROPOS DE CINQ OBSERVATIONSRAHAL JOSEPH.1980; ; FRA; DA. 1980; 796; 97-XIII P.: ILL.; 30 CM; BIBL. 97 REF.; TH.: MED./ANGERS/1980Thesis

Clavines: new antibiotics with cytostatic activityEICH, E; EICHBERG, D; MÜLLER, W. E. G et al.Biochemical pharmacology. 1984, Vol 33, Num 4, pp 523-526, issn 0006-2952Article

Hemodynamic effects of two ergot derivatives in the conscious spontaneously hypertensive ratSUSIC, D; DJORDJEVIC, N; KENTERA, D et al.Pharmacology. 1984, Vol 29, Num 4, pp 215-223, issn 0031-7012Article

Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesiaBERGSTROM, D. A; BROMLEY, S. D; WALTERS, J. R et al.European journal of pharmacology. 1984, Vol 100, Num 1, pp 3-12, issn 0014-2999Article

Radioreceptor assay for ergot derivatives, transdihydrolisuride and lisuride, in biological fluidsLAPKA, R; SMOLIK, S; FRANC, Z et al.Journal of pharmacological methods. 1984, Vol 11, Num 4, pp 263-270, issn 0160-5402Article

ERGOTS REVISITED-PHARMACOLOGY OF NEW ERGOT DERIVATIVES.1978; FEDER. PROC.; U.S.A.; DA. 1978; VOL. 37; NO 8; PP. 2176-2209; BIBL. DISSEM.Article

INTERNATIONAL WORKSHOP ON ERGOT ALKALOIDS; ROME; 1976.1978; PHARMACOLOGY; SWITZ.; DA. 1978; VOL. 16; SUPPL. 1; PP. 1-213; BIBL. DISSEM.Conference Paper

Pharmacokinetics of dihydroergotamine following subcutaneous administration in humansSCHRAN, H. F; TSE, F. L. S.International journal of clinical pharmacology, therapy and toxicology (1980). 1985, Vol 23, Num 1, pp 1-4, issn 0174-4879Article

CONSIDERAZIONI SU ALCUNI ASPETTI FARMACOLOGICI DEGLI ALCALOIDI DELLA SEGALE CORNUTA = CONSIDERATIONS SUR QUELQUES ASPECTS PHARMACOLOGIQUES DES ALCALOIDES DE L'ERGOT DU SEIGLEGENAZZANI E; PORTALEONE P; FONZO D et al.1978; G. ACCAD. MED. TORINO; ITA; DA. 1978 PUBL. 1979; VOL. 141; NO 1-12; PP. 1-19; BIBL. 34 REF.Article

Interaction of lisuride with monoamine receptors on human blood plateletsGLUSA, E; MARKWARDT, F.Biochemical pharmacology. 1984, Vol 33, Num 3, pp 493-496, issn 0006-2952Article

Intérêt et place du vasobral dans les troubles périménopausiques = Interest and place of vasdoral in perimenopausal disordersCOSSARD, F; PAUQUET, M; SENTENAC, J et al.Gazette médicale de France (1969). 1985, Vol 92, Num 33, pp 100-103, issn 0016-5557Article

ACTIONS DES DERIVES DE L'ERGOT DE SEIGLE SUR LE SYSTEME NERVEUX CENTRALVIGOURET JM; LOEW DM; JATON AL et al.1979; J. PHARMACOL.; FRA; DA. 1979; VOL. 10; NO 4BIS; PP. 503-515; ABS. ENG; BIBL. 25 REF.Article

EL ERGOTISMO YATROGENICO: A PROPOSITO DE UN CASO. = L'ERGOTISME IATROGENIQUE. A PROPOS D'UN CASFERNANDEZ J; DE QUIROS B.1978; REV. CLIN. ESP.; ESP; DA. 1978; VOL. 149; NO 3; PP. 309-313; BIBL. 49 REF.Article

THIN-LAYER CHROMATOGRAPHY OF SOME ERGOT ALKALOIDS.SALLAM LAR; NAIM N; EL REFAI AH et al.1977; Z. (FRESENIUS') ANAL. CHEM.; DTSCH.; DA. 1977; VOL. 284; NO 1; PP. 47-48Article

Cabergoline : a new drug for the treatment of hyperprolactinaemiaFERRARI, C; PISCITELLI, G; CROSIGNANI, P. G et al.Human reproduction (Oxford. Print). 1995, Vol 10, Num 7, pp 1647-1652, issn 0268-1161Article

Ergotamine-induced peripheral ischaemia reversed by oral thymoxamine hydrochlorideJONES, N. S; LEWIS, L. D.Human toxicology. 1986, Vol 5, Num 1, pp 61-62, issn 0144-5952Article

ERGOT ALKALOIDS AND THEIR BIOSYNTHESISREHACEK Z.1980; ADV. BIOCHEM. ENGNG; DEU; DA. 1980; VOL. 14; PP. 33-60; BIBL. 192 REF.Article

IDENTIFICATION OF ERGOT-PEPTIDE ALKALOIDS, BASED ON GAS-LIQUID CHROMATOGRAPHY OF THE PEPTIDE MOIETY.VAN MANSVELT FJW; GREVING JE; DE ZEEUW RA et al.1978; J. CHROMATOGR.; NETHERL.; DA. 1978; VOL. 151; NO 2; PP. 113-120; BIBL. 19 REF.Article

BIOSYNTHESIS OF ERGOT ALKALOIDS. CELL-FREE FORMATION OF THREE PRODUCTS FROM L-TRYPTOPHAN AND ISOPENTENYLPYROPHOSPHATE AND THEIR INCORPORATION INTO LYSERGIC ACID AMIDEPETROSKI RJ; KELLEHER WJ.1978; LLOYDIA; USA; DA. 1978; VOL. 41; NO 4; PP. 332-341; BIBL. 16 REF.Article

BIOSYNTHESIS OF ERGOT ALKALOIDS. CELL-FREE FORMATION OF 4-(E-4'-HYDROXY-3'-METHYL-BUT-2'-ENYL)-L-TRYPTOPHAN.PETROSKI RJ; KELLEHER WJ.1977; F.E.B.S. LETTERS; NETHERL.; DA. 1977; VOL. 82; NO 1; PP. 55-57; BIBL. 11 REF.Article

The biologically active conformation of ergot alkaloidsKIDRIC, J; KOEJAN, D; HADZI, D et al.Experientia. 1986, Vol 42, Num 3, pp 327-328, issn 0014-4754Article

CLINICAL PHARMACOKINETICS OF METHYLERGOMETRINE (METHYLERGANOVINE)MANTYLA R; KANTO J.1981; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1981; VOL. 19; NO 9; PP. 386-391; BIBL. 2 P.Article

ERGOT COMPOUNDS AND BRAIN FUNCTION. NEUROENDOCRINE AND NEUROPSYCHIATRIC ASPECTSGOLDSTEIN M ED; CALNE DB ED; LIEBERMAN A ED et al.1980; ADV. BIOCHEM. PSYCHOPHARMACOL.; NLD; DA. 1980; VOL. 23; XVIII-413 P.; BIBL. DISSEM.Conference Paper

  • Page / 77